Illumina Stock News

Precisely figuring out toxic stocks and discarding or short selling those at the right time is the key to safeguarding your portfolio from big losses.

Global Mutational Analysis Market Synopsis: An entire Mutational Analysis Market report is spread across more than 350 pages, list of tables & figures, profiling more than ten companies. Analysis and estimations attained through the massive information gathered in this Market report

Analysts expect that Illumina, Inc. (NASDAQ:ILMN) will post $0.50 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for Illuminas earnings, with the lowest EPS estimate coming in at $0.40 and the highest estimate coming in at $0.68. Illumina posted earnings of $1.22 per share during []

New Jersey, United Kingdom, Nov. 21, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled "Consumer Genomics Market By Application (Diagnostics, Genetic Relatedness, Nutrition, Wellness, & Lifestyle, Reproductive Health, Ancestry, Sports Nutrition & Health, Pharmacogenetic Testing, Personalized Medicine, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 2026" in its research database "According to the latest research study, the demand of global Consumer Genomics Market size & share expected to reach to USD 5,230 Million by 2026 from USD 1,440 Million in 2019, at a compound annual growth rate (CAGR) of 20.2% during the forecast period 2020 to 2026" What is Consumer Genomics? Report Overview & Coverage: Consumer genomics is a stream of genomics that includes the sampling, analysis, and description of a person''s genome. The consumer genomics sector is evolving steadily and rapidly into a normal view. Market genomics has a large role to play in pushing forward new concepts and their implementations to the majority.

The Next Generation Sequencing (NGS) Product Market research report presents a top-notch analysis that incorporates market restaurants, drivers, and opportunities available in the market. The report also segments the market by how a competitive environment is developed among leading players

The Companion Diagnostics for Oncology Market research report focuses on consolidations and acquisitions, extensions, examination of central participants, the foundation date of organization regions served, fabricating base, and income of vital participants. Moreover, the report also studies breakdown by product

First use of the European Commissions new referral policy and failure by the parties to comply with their standstill obligation. Please see full Publication below for more information. By: Allen & Overy LLP

DUBLIN--(BUSINESS WIRE)--The "Global Cancer Microbiome Sequencing Market - Analysis and Forecast, 2021-2031" report has been added to ResearchAndMarkets.com''s offering. The market is driven by certain factors, which include increasing emphasis on the microbiome''s potential in the field of cancer, growing cancer prevalence, and decreasing cost of sequencing are fueling the growth of the global cancer microbiome sequencing market. Companies Mentioned Cosmos ID Illumina, Inc. Invivo Diagnostics Me

SAN DIEGO, Nov. 17, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), and Sequoia Capital China, a leading investment firm, today jointly announced the selection of the first two startup companies joining the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by

DUBLIN--(BUSINESS WIRE)--The "Lung Cancer Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com''s offering. Amid the COVID-19 crisis, the global market for Lung Cancer Diagnostics estimated at US$2.5 Billion in the year 2020, is projected to reach a revised size of US$4.3 Billion by 2027, growing at a CAGR of 8.1% over the analysis period 2020-2027. Imaging Tests, one of the segments analyzed in the report, is projected to grow at a 8% CAGR to r

Illumina's (ILMN) launch of iHope Genetic Health program will expand access to WGS to low- and middle-income communities worldwide.

The global market for pre-pregnancy genetic testing is growing as more expecting mothers become aware of the benefits of performing hereditary testing at the right time. This allows parents to prepare emotionally and financially to support a child who may

Related Stocks: VEA , ABBV , JNJ , VB , AVGO , ABT , ZD , CHY , IDXX , VTI , ARCC , VXUS , SCHX , EL , ESBA , QUAL , CL , ILMN ,